🎗️ OncologyInjection (IV)
Elzonris
Tagraxofusp
CD123-directed cytotoxin for treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Form
Injection (IV)
Uses
1
Side effects
5
Category
Oncology
01
What is Elzonris used for?
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
02
Tagraxofusp side effects
Common side effects of Tagraxofusp include:
Capillary leak syndrome
Nausea
Fatigue
Peripheral edema
Hypoalbuminemia
CommonModerateLess common
03
Tagraxofusp warnings & precautions
- Black box: capillary leak syndrome. May be fatal, monitor albumin daily
- Premedication required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Elzonris in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.